Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Official NIH NLM MEDLINE / PubMed Citation • PMID: 42980819

Efficacy and safety of cenobamate in the treatment of drug-resistant epilepsy: a systematic review and meta-analysis in adult, pediatric, and combined populations

European journal of clinical pharmacology

Verbatim Formal Study Abstract

In summary, this is the first comprehensive meta-analysis to evaluate the efficacy and safety of CNB across pediatric, adult, and combined populations. Although pediatric point estimates were numerically similar to adult estimates, these findings are derived from indirect subgroup comparisons and should be interpreted cautiously.